EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
EVFM
Delisted
EVFM was delisted on the 10th of August, 2022.
81 hedge funds and large institutions have $40.8M invested in Evofem Biosciences, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 24 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
58% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 38
Holders
81
Holding in Top 10
–
Calls
$2.59M
Puts
$1.29M
Top Buyers
| 1 | +$4.52M | |
| 2 | +$4.31M | |
| 3 | +$3.75M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.21M |
| 5 |
Renaissance Technologies
New York
|
+$1.7M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$4.83M | |
| 3 | -$4.09M | |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
-$2.97M |
| 5 |
BlackRock
New York
|
-$2.5M |